Skip to main content
Clinical Trials/NCT05386641
NCT05386641UnknownNot Applicable

Risk Factors for Shoulder Joint Motion Restriction in Breast Cancer Survivors

Istanbul Medeniyet University1 site in 1 country72 target enrollmentStarted: August 15, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
72
Locations
1
Primary Endpoint
measurement of the range of shoulder joint motion

Study Overview

Brief Summary

In breast cancer patients, limitation of shoulder joint movement may occur following cancer treatment. Shoulder limitation causes a significant decrease in the patient's participation in activities of daily living. The aim of the study is to define these limitations, to evaluate in detail all the structures that cause the problem, and to determine the causes of the limitations in patients with shoulder joint movement limitation developed after breast cancer survivors.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
30 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Women between the ages of 30-60
  • Having breast cancer treatment within 5 years

Exclusion Criteria

  • Not having agreed to participate in the study
  • Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing spondylitis, rheumatoid arthritis, etc.) that will affect upper extremity functions

Outcomes

Primary Outcomes

measurement of the range of shoulder joint motion

Time Frame: Baseline

The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.

measurement of tissue stiffness (N/m)

Time Frame: Baseline

Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain

measurement of passive muscle tone (Hz)

Time Frame: Baseline

muscle tones will be measured with myotonPro on centers of coordination located along the myofascial chain

measurement of creep of tissue

Time Frame: Baseline

creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain

Secondary Outcomes

  • measurement of pain(Baseline)
  • measurement of grip strength(Baseline)
  • measurement of skin temperature(Baseline)
  • measurement of pain pressure threshold(Baseline)

Investigators

Sponsor
Istanbul Medeniyet University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nilufer Kablan

Principal Investigator

Istanbul Medeniyet University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast CancerBreast Cancer
NCT04837248Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal92
Completed
Not Applicable
The Effect of Myofascial Chain Release Techniques on Shoulder Joint Range of Motion in Breast Cancer SurvivorsBreast Cancer Survivors
NCT05386628Istanbul Medeniyet University36
Completed
Not Applicable
Effect of Thera Band Exercises on Adhesive Capsulitis Post MastectomyAdhesive Capsulitis of Shoulder
NCT05311839Maged Basha70
Completed
Not Applicable
Accessory Joint and Neural Mobilizations in Shoulder After Breast Cancer Surgery. Randomized Clinical Trial.Breast Cancer
NCT02366793University of Alcala18
Terminated
Not Applicable
Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and HandAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Hormone Receptor Positive Breast AdenocarcinomaPrognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8
NCT04876378University of California, San Francisco8